Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 6 , Pages 929-939 , December 2008

Fine-needle aspiration of the thyroid: today and tomorrow

References 

  1. Baloch ZW, Cibas ES, Clark DP, et al. The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation. Cytojournal. 2008;5:6
  2. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16:109–142
  3. Baskin HJ, Duick DS. The endocrinologists' view of ultrasound guidelines for fine needle aspiration. Thyroid. 2006;16:207–208
  4. Guidelines of the Papanicolaou Society of Cytopathology for the examination of fine-needle aspiration specimens from thyroid nodules. The Papanicolaou Society of Cytopathology Task Force on Standards of Practice. Diagnostic Cytopathology. 1996;15:84–89
  5. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocrine Practice. 2006;12:63–102
  6. Murray D. The thyroid gland. Malden, MA: Blackwell Science; 1998;295–380
  7. Baloch Z, LiVolsi VA. Pathology of the thyroid gland. Philadelphia, PA: Churchill Livingston; 2002;61–88
  8. Kini SR. Guides to clinical aspiration biopsy thyroid. 2nd edn.. New York, NY: Igaku-Shoin; 1996;
  9. Layfield LJ, Wax T, Jones C. Cytologic distinction of goiterous nodules from morphologically normal thyroid: analyses of cytomorphologic features. Cancer. 2003;99:217–222
  10. Baloch ZW, Sack MJ, Yu GH, et al. Fine-needle aspiration of thyroid: an institutional experience. Thyroid. 1998;8:565–569
  11. Oertel YC, Oertel JE. Thyroid cytology and histology. Baillière’s Best Practice & Research. Clinical Endocrinology & Metabolism. 2000;14:541–557
  12. Centeno BA, Szyfelbein WM, Daniels GH, et al. Fine needle aspiration biopsy of the thyroid gland in patients with prior Graves' disease treated with radioactive iodine. Morphologic findings and potential pitfalls. Acta Cytologica. 1996;40:1189–1197
  13. Anderson SR, Mandel S, LiVolsi VA, et al. Can cytomorphology differentiate between benign nodules and tumors arising in Graves' disease?. Diagnostic Cytopathology. 2004;31:64–67
  14. Kim WB, Han SM, Kim TY, et al. Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease. Clinical Endocrinology. 2004;60:719–725
  15. Cantalamessa L, Baldini M, Orsatti A, et al. Thyroid nodules in Graves disease and the risk of thyroid carcinoma. Archives of Internal Medicine. 1999;159:1705–1708
  16. Carson HJ, Castelli MJ, Gattuso P. Incidence of neoplasia in Hashimoto's thyroiditis: a fine-needle aspiration study. Diagnostic Cytopathology. 1996;14:38–42
  17. Liu LH, Bakhos R, Wojcik EM. Concomitant papillary thyroid carcinoma and Hashimoto's thyroiditis. Seminars in Diagnostic Pathology. 2001;18:99–103
  18. Kumar N, Ray C, Jain S. Aspiration cytology of Hashimoto's thyroiditis in an endemic area. Cytopathology. 2002;13:31–39
  19. MacDonald L, Yazdi HM. Fine needle aspiration biopsy of Hashimoto's thyroiditis. Sources of diagnostic error. Acta Cytologica. 1999;43:400–406
  20. Mechler C, Bounacer A, Suarez H, et al. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements. British Journal of Cancer. 2001;85:1831–1837
  21. Kumarasinghe MP, De Silva S. Pitfalls in cytological diagnosis of autoimmune thyroiditis. Pathology. 1999;31:1–8
  22. Baloch ZW, Fleisher S, LiVolsi VA, et al. Diagnosis of ‘follicular neoplasm’: a gray zone in thyroid fine-needle aspiration cytology. Diagnostic Cytopathology. 2002;26:41–44
  23. Renshaw AA. Follicular lesions of the thyroid. American Journal of Clinical Pathology. 2001;115:782–785
  24. Sidawy MK, Del Vecchio DM, Knoll SM. Fine-needle aspiration of thyroid nodules: correlation between cytology and histology and evaluation of discrepant cases. Cancer. 1997;81:253–259
  25. Pu RT, Yang J, Wasserman PG, et al. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?. Diagnostic Cytopathology. 2006;34:330–334
  26. Deveci MS, Deveci G, LiVolsi VA, et al. Fine-needle aspiration of follicular lesions of the thyroid. Diagnosis and follow-Up. Cytojournal. 2006;3:9
  27. Clary KM, Condel JL, Liu Y, et al. Interobserver variability in the fine needle aspiration biopsy diagnosis of follicular lesions of the thyroid gland. Acta Cytologica. 2005;49:378–382
  28. Tuttle RM, Lemar H, Burch HB. Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid. 1998;8:377–383
  29. Yang J, Schnadig V, Logrono R, et al. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer. 2007;111:306–315
  30. Elliott DD, Pitman MB, Bloom L, et al. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: a cytomorphologic study of 139 cases with statistical analysis. Cancer. 2006;108:102–109
  31. Oertel YC. Fine-needle aspiration in the evaluation of thyroid neoplasms. Endocrine Pathology. 1997;8:215–224
  32. Das DK, Mallik MK, Sharma P, et al. Papillary thyroid carcinoma and its variants in fine needle aspiration smears. A cytomorphologic study with special reference to tall cell variant. Acta Cytologica. 2004;48:325–336
  33. Baloch ZW, LiVolsi VA. Cytologic and architectural mimics of papillary thyroid carcinoma. Diagnostic challenges in fine-needle aspiration and surgical pathology specimens. American Journal of Clinical Pathology. 2006;125(Suppl):S135–S144
  34. Albores-Saavedra J, Wu J. The many faces and mimics of papillary thyroid carcinoma. Endocrine Pathology. 2006;17:1–18
  35. Zacks JF, de las Morenas A, Beazley RM, et al. Fine-needle aspiration cytology diagnosis of colloid nodule versus follicular variant of papillary carcinoma of the thyroid. Diagnostic Cytopathology. 1998;18:87–90
  36. Solomon A, Gupta PK, LiVolsi VA, et al. Distinguishing tall cell variant of papillary thyroid carcinoma from usual variant of papillary thyroid carcinoma in cytologic specimens. Diagnostic Cytopathology. 2002;27:143–148
  37. Collins BT, Cramer HM, Tabatowski K, et al. Fine needle aspiration of medullary carcinoma of the thyroid. Cytomorphology, immunocytochemistry and electron microscopy. Acta Cytologica. 1995;39:920–930
  38. Wan SK, Chan JK, Tang SK. Paucicellular variant of anaplastic thyroid carcinoma. A mimic of Reidel's thyroiditis. American Journal of Clinical Pathology. 1996;105:388–393
  39. LiVolsi VA. Surgical pathology of the thyroid. Philadelphia, PA: WB Saunders; 1990;
  40. Cheung CC, Ezzat S, Freeman JL, et al. Immunohistochemical diagnosis of papillary thyroid carcinoma. Modern Pathology. 2001;14:338–342
  41. Sapio MR, Guerra A, Posca D, et al. Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma. Endocrine-Related Cancer. 2007;14:1089–1097
  42. Barroeta JE, Baloch ZW, Lal P, et al. Diagnostic value of differential expression of CK19, Galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: an immunohistochemical tissue microarray analysis. Endocrine Pathology. 2006;17:225–234
  43. Nikiforov YE. RET/PTC rearrangement in thyroid tumors. Endocrine Pathology. 2002;13:3–16
  44. Fischer AH, Bond JA, Taysavang P, et al. Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure. The American Journal of Pathology. 1998;153:1443–1450
  45. Zou M, Shi Y, Farid NR. Low rate of ret proto-oncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia. Cancer. 1994;73:176–180
  46. Motomura T, Nikiforov YE, Namba H, et al. ret rearrangements in Japanese pediatric and adult papillary thyroid cancers. Thyroid. 1998;8:485–489
  47. Domingues R, Mendonca E, Sobrinho L, et al. Searching for RET/PTC rearrangements and BRAF V599E mutation in thyroid aspirates might contribute to establish a preoperative diagnosis of papillary thyroid carcinoma. Cytopathology. 2005;16:27–31
  48. Sapio MR, Posca D, Raggioli A, et al. Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. Clinical Endocrinology. 2007;66:678–683
  49. Pizzolanti G, Russo L, Richiusa P, et al. Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement. Thyroid. 2007;17:1109–1115
  50. Papotti M, Volante M, Giuliano A, et al. RET/PTC activation in hyalinizing trabecular tumors of the thyroid. The American Journal of Surgical Pathology. 2000;24:1615–1621
  51. Wirtschafter A, Schmidt R, Rosen D, et al. Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. [see comments] The Laryngoscope. 1997;107:95–100
  52. Elisei R, Romei C, Vorontsova T, et al. RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. Journal of Clinical Endocrinology & Metabolism. 2001;86:3211–3216
  53. Inaba M, Umemura S, Satoh H, et al. Expression of RET in follicular cell-derived tumors of the thyroid gland: prevalence and implication of morphological type. Pathology International. 2003;53:146–153
  54. Daum G, Eisenmann-Tappe I, Fries HW, et al. The ins and outs of Raf kinases. Trends in Biochemical Sciences. 1994;19:474–480
  55. Cohen Y, Xing M, Mambo E, et al. BRAF mutation in papillary thyroid carcinoma. Journal of the National Cancer Institute. 2003;95:625–627
  56. Kimura ET, Nikiforova MN, Zhu Z, et al. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Research. 2003;63:1454–1457
  57. Fagin JA. How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy. The Journal of Endocrinology. 2004;183:249–256
  58. Lubitz CC, Ugras SK, Kazam JJ, et al. Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions. The Journal of Molecular Diagnostics. 2006;8:490–498quiz 528

PII: S1521-690X(08)00103-6

doi: 10.1016/j.beem.2008.09.011

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 6 , Pages 929-939 , December 2008

Article Tools

* Image Usage & Resolution